Pancreatic Cancer Clinical Trials in Georgia

Cancer Type = Pancreatic Cancer

Cancer Type = Pancreatic Cancer

There are currently 11 active Pancreatic Cancer clinical trials in Georgia.
1.
A Phase 1 Multiple-Dose Study to Evaluate the Safety and Tolerability of XmAb®22841 Monotherapy and in Combination With Pembrolizumab in Subjects With Selected Advanced Solid Tumors (DUET-4)
Cancer Type
Breast Cancer, Cervical Cancer, Colon/Rectal Cancer, Eye Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Melanoma, Pancreatic Cancer, Prostate Cancer , Skin Cancer (Non-Melanoma), Stomach/ Gastric Cancer, Unknown Primary
NCI ID
NCT03849469
Protocol IDs
XmAb22841-01
NCI-2019-02498
DUET-4
2.
A Phase 1, Open-Label, Dose-Finding Study Of ASN007 In Patients With Advanced Solid Tumors
Cancer Type
Colon/Rectal Cancer, Lung Cancer, Melanoma, Pancreatic Cancer, Skin Cancer (Non-Melanoma), Unknown Primary
NCI ID
NCT03415126
Protocol IDs
ASN007-101
NCI-2018-00820
4.
A Phase I / II Study of Trifluridine / Tipiracil (TAS102) in Combination with Nanoliposomal Irinotecan (NAL-IRI) in Advanced GI Cancers
Cancer Type
Pancreatic Cancer, Stomach/ Gastric Cancer, Unknown Primary
NCI ID
NCT03368963
Protocol IDs
Winship4146-17
NCI-2017-01661
IRB00098958
7.
Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Selected Solid Tumors
Cancer Type
Lung Cancer, Pancreatic Cancer, Skin Cancer (Non-Melanoma), Unknown Primary
NCI ID
NCT03485209
Protocol IDs
SGNTV-001
NCI-2018-00676
8.
Phase 1 Study of ADI PEG 20 Plus FOLFOX in Subjects With Advanced Gastrointestinal Malignancies
Cancer Type
Pancreatic Cancer, Stomach/ Gastric Cancer
NCI ID
NCT02102022
Protocol IDs
POLARIS2013-001
NCI-2017-00851
9.
Phase I Integrated Biomarker Trial of VX15 / 2503 in Combination with Ipilimumab or Nivolumab in Patients with Pancreatic and Colorectal Cancer
Cancer Type
Colon/Rectal Cancer, Pancreatic Cancer, Unknown Primary
NCI ID
NCT03373188
Protocol IDs
Winship4142-17
NCI-2017-01618
IRB00098707
10.
Phase II Randomized, Double-Blind Study of mFOLFIRINOX plus Ramucirumab versus mFOLFIRINOX plus Placebo in Advanced Pancreatic Cancer Patients
Cancer Type
Pancreatic Cancer
NCI ID
NCT02581215
Protocol IDs
HCRNGI14-198
NCI-2016-00206
IRB00086601
Winship3142-16
11.
Weight Loss in Patients with Advanced Stage Pancreatic Cancer: Role of Serotonin and Effects of Telotristat Ethyl
Cancer Type
Pancreatic Cancer, Unknown Primary
NCI ID
NCT03910387
Protocol IDs
Winship4441-18
NCI-2018-01977
IRB00105292
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.